These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8201528)

  • 21. Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.
    Imura Y; Stassen JM; Bunting S; Stockmans F; Collen D
    Blood; 1992 Sep; 80(5):1247-53. PubMed ID: 1515641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia.
    Sheu JR; Hung WC; Wu CH; Ma MC; Kan YC; Lin CH; Lin MS; Luk HN; Yen MH
    Circulation; 1999 Jun; 99(23):3056-62. PubMed ID: 10368125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Triflavin, an Arg-Gly-Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism.
    Sheu JR; Lin CH; Peng HC; Huang TF
    Peptides; 1994; 15(8):1391-8. PubMed ID: 7700842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kistrin, an integrin antagonist, blocks endocytosis of fibrinogen into guinea pig megakaryocyte and platelet alpha-granules.
    Handagama P; Bainton DF; Jacques Y; Conn MT; Lazarus RA; Shuman MA
    J Clin Invest; 1993 Jan; 91(1):193-200. PubMed ID: 8423218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of glycoprotein IIb/IIIa mediates the antithrombotic activity of butanol fraction of Actinostemma lobatum Maxim.
    Kim KH; Lee HJ; Lee JH; Jang YS; Kim DK; Shim BS; Cho KH; Ko SG; Ahn KS; Kim SH
    J Ethnopharmacol; 2008 Mar; 116(3):431-8. PubMed ID: 18243609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trowaglerix Venom Polypeptides As a Novel Antithrombotic Agent by Targeting Immunoglobulin-Like Domains of Glycoprotein VI in Platelet.
    Chang CH; Chung CH; Tu YS; Tsai CC; Hsu CC; Peng HC; Tseng YJ; Huang TF
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1307-1314. PubMed ID: 28596377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: evidence for a family of platelet-aggregation inhibitors.
    Dennis MS; Henzel WJ; Pitti RM; Lipari MT; Napier MA; Deisher TA; Bunting S; Lazarus RA
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2471-5. PubMed ID: 2320569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthesized 1,4-naphthoquinone derivative.
    Yuk DY; Ryu CK; Hong JT; Chung KH; Kang WS; Kim Y; Yoo HS; Lee MK; Lee CK; Yun YP
    Biochem Pharmacol; 2000 Oct; 60(7):1001-8. PubMed ID: 10974210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trimucytin: a collagen-like aggregating inducer isolated from Trimeresurus mucrosquamatus snake venom.
    Teng CM; Ko FN; Tsai IH; Hung ML; Huang TF
    Thromb Haemost; 1993 Mar; 69(3):286-92. PubMed ID: 8470053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.
    Mousa SA; Bozarth JM; Forsythe MS; Jackson SM; Leamy A; Diemer MM; Kapil RP; Knabb RM; Mayo MC; Pierce SK
    Circulation; 1994 Jan; 89(1):3-12. PubMed ID: 8281661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological properties of YM-57029, a novel platelet glycoprotein IIb/IIIa antagonist.
    Moritani Y; Sato K; Shigenaga T; Hisamichi N; Ichihara M; Akamatsu S; Suzuki Ki; Nii T; Kaku S; Kawasaki T; Matsumoto Y; Inagaki O; Tomioka K; Yanagisawa I
    Eur J Pharmacol; 2002 Mar; 439(1-3):43-52. PubMed ID: 11937091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purification and characterization of a new RGD/KGD-containing dimeric disintegrin, piscivostatin, from the venom of Agkistrodon piscivorus piscivorus: the unique effect of piscivostatin on platelet aggregation.
    Okuda D; Morita T
    J Biochem; 2001 Sep; 130(3):407-15. PubMed ID: 11530017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Species-dependent specificity of platelet aggregation inhibitors from snake venom.
    Lombardi P; Pelagalli A; Avallone L; d'Angelo D; Belisario MA; d'Angelo A; Staiano N
    J Comp Pathol; 1999 Aug; 121(2):185-90. PubMed ID: 10507910
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of vintoperol on platelet aggregation and experimental thrombosis.
    Csomor K; Kárpáti E
    Arzneimittelforschung; 1994 Jan; 44(1):36-40. PubMed ID: 8135876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical characterization of a new disintegrin, flavostatin, isolated from Trimeresurus flavoviridis venom.
    Kawasaki T; Sakai Y; Taniuchi Y; Sato K; Maruyama K; Shimizu M; Kaku S; Yano S; Inagaki O; Tomioka K; Yanagisawa I; Takenaka T
    Biochimie; 1996; 78(4):245-52. PubMed ID: 8874799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and amino acid sequence of flavostatin, a novel disintegrin from the venom of Trimeresurus flavoviridis.
    Maruyama K; Kawasaki T; Sakai Y; Taniuchi Y; Shimizu M; Kawashima H; Takenaka T
    Peptides; 1997; 18(1):73-8. PubMed ID: 9114455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminopeptidase resistant Arg-Gly-Asp analogs are stable in plasma and inhibit platelet aggregation.
    Fok KF; Panzer-Knodle SG; Nicholson NS; Tjoeng FS; Feigen LP; Adams SP
    Int J Pept Protein Res; 1991 Aug; 38(2):124-30. PubMed ID: 1783488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antithrombotic and thrombolytic activities of Agkisacutacin, a snake venom proteinase, in experimental models.
    Li S; Ji H; Cheng X; Li BX; Ng TB
    Gen Pharmacol; 2000 Oct; 35(4):179-87. PubMed ID: 11827724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.